Aspire Biopharma Holdings, Inc. clarified the terms of its public warrants (ASBPW) following two previous reverse stock splits. A 1-for-30 reverse split occurred on January 16, 2026, and a 40-1 reverse split occurred on May 11, 2026. Consequently, the warrants now have an exercise price of $13,800 per share and a conversion ratio of 1,200 warrants to purchase one share of common stock. The company operates in the biopharmaceutical industry, focusing on the development of therapeutic drugs.